Readycell develops, implements and commercialize new innovative kits through strategic partnership with other emerging market players: Biotechnological, Pharmaceutical & Med Dev companies and Research Centers.
- R+D support projects with high predictable and/or regulatory value.
- Acceleration and optimization of decision-making process.
- Evaluation of active molecules: Action, mechanisms, ADME, Efficacy, Toxicity, Screening and optimization, Active concept proof and NCEs (New Chemical Entities).
- In silico modeling and Bioinformatic analysis.
- High throughput in vivo studies in Zebrafish
- Custom projects.